Skip to site menu Skip to page content

Daily Newsletter

09 January 2025

Daily Newsletter

09 January 2025

Anumana and AliveCor to co-develop AI algorithms for cardiac disease detection

AliveCor recently introduced the Kardia 12L ECG System for healthcare professionals.

gullapalli January 08 2025

US-based health technology company Anumana has partnered with AliveCor for the development of its AI algorithms intended for the early identification of cardiac diseases.

The collaboration will initially integrate Anumana's ECG-AI LEF algorithm into AliveCor's Kardia electrocardiogram (ECG) devices.

AliveCor recently introduced the Kardia 12L ECG system for healthcare professionals.

A handheld, AI-powered 12-lead resting ECG system, Kardia 12L features a ‘unique’ single-cable design that simplifies lead placement, allowing even those with limited ECG experience to obtain accurate recordings quickly.

This system is set to benefit from Anumana's ECG-AI LEF algorithm, which is approved by the US Food and Drug Administration (FDA) and uses routine 12-lead ECG data to identify left ventricular ejection fraction (LEF), a key indicator of heart failure that is often underdiagnosed.

AliveCor chief business officer Sanjay Voleti said: “AliveCor is already at the forefront of AI in cardiology, transforming the industry with clinically validated solutions that disrupt traditional care pathways to create a more connected, holistic cardiac health ecosystem – like the recently FDA-cleared Kardia 12L ECG System.

“This collaboration with Anumana will further strengthen our leadership in AI by expanding our solutions' ability to facilitate more personalised and timely care across diverse healthcare settings.”

Founded by nference in partnership with Mayo Clinic, Anumana is an AI-driven health technology company that focuses on transforming ECG-AI technology into a practical tool for clinicians.

Anumana chief business officer David McMullin said: “Together with AliveCor, we are reshaping the future of cardiac care by unlocking new possibilities for early detection and intervention.

“This collaboration demonstrates Anumana’s commitment to harnessing the potential of AI to expand the utility of ECG technology, making traditional diagnostic tools more powerful for patients and clinicians.”

AliveCor is a medical device company specialising in AI-enabled ECG sensor technologies.

In June 2023, the ECG-AI algorithm received breakthrough device designation (BDD) from the FDA.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close